Prognostic Importance of Survivin in Breast Cancer

Overview

Journal Br J Cancer

Specialty Oncology

Date 2003 Apr 3

PMID 12671708

Citations 84

Authors

S M Kennedy

L ODriscoll

R Purcell

N Fitz-Simons

E W McDermott

A D Hill

N J OHiggins

M Parkinson

R Linehan

M Clynes

Affiliations

Soon will be listed here.

Abstract

Survivin is a member of the inhibitor of apoptosis (IAP) family, and is also involved in the regulation of cell division. Survivin is widely expressed in foetal tissues and in human cancers, but generally not in normal adult tissue. This study examined the expression of surviving protein in a series of 293 cases of invasive primary breast carcinoma. Survivin immunoreactivity was assessed using two different polyclonal antibodies, and evaluated semiquantitatively according to the percentage of cells demonstrating distinct nuclear and/or diffuse cytoplasmic staining. Overall, 60% of tumours were positive for survivin: 31% demonstrated nuclear staining only, 13% cytoplasmic only, and 16% of tumour cells demonstrated both nuclear and cytoplasmic staining. Statistical analysis revealed that survivin expression was independent of patient's age, tumour size, histological grade, nodal status, and oestrogen receptor status. In multivariate analysis, nuclear survivin expression was a significant independent prognostic indicator of favourable outcome both in relapse-free and overall survival (P<0.001 and P=0.01, respectively). In conclusion, our results show that survivin is frequently overexpressed in primary breast cancer. Nuclear expression is most common and is an independent prognostic indicator of good prognosis.

Citing Articles

The impact of quercetin and paclitaxel combination on ovarian cancer cells.

Ji H, Zhang Z, Chen C, Xu W, Liu T, Dong Y iScience. 2024; 27(8):110434.

PMID: 39108714 PMC: 11301342. DOI: 10.1016/j.isci.2024.110434.

Survivin as a Therapeutic Target for the Treatment of Human Cancer.

Wang Q, Greene M Cancers (Basel). 2024; 16(9).

PMID: 38730657 PMC: 11083197. DOI: 10.3390/cancers16091705.

Prognostic value of XIAP and survivin expression in locally advanced breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy.

Pluta P, Jesionek-Kupnicka D, Pluta A, Brzozowski K, Braun M, Kubicka-Wolkowska J Arch Med Sci. 2023; 19(2):343-354.

PMID: 37034529 PMC: 10074301. DOI: 10.5114/aoms.2019.88509.

Valproic acid inhibits cell growth in both MCF-7 and MDA-MB231 cells by triggering different responses in a cell type-specific manner.

Giordano F, Paoli A, Forastiero M, Marsico S, De Amicis F, Marrelli M J Transl Med. 2023; 21(1):165.

PMID: 36864445 PMC: 9983172. DOI: 10.1186/s12967-023-04015-8.

Significance of combined TGF-β1 and survivin expression on the prognosis of patients with triple-negative breast cancer.

Liu N, Qi D, Jiang J, Zhang J, Yu C Oncol Lett. 2022; 23(6):193.

PMID: 35527782 PMC: 9073572. DOI: 10.3892/ol.2022.13313.

References

Takano Y, Kato Y, van Diest P, Masuda M, Mitomi H, Okayasu I . Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases. Am J Pathol. 2000; 156(2):585-94. PMC: 1850035. DOI: 10.1016/S0002-9440(10)64763-3. View

Swana H, Grossman D, Anthony J, Weiss R, Altieri D . Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer. N Engl J Med. 1999; 341(6):452-3. DOI: 10.1056/NEJM199908053410614. View

Ito T, Shiraki K, Sugimoto K, Yamanaka T, Fujikawa K, Ito M . Survivin promotes cell proliferation in human hepatocellular carcinoma. Hepatology. 2000; 31(5):1080-5. DOI: 10.1053/he.2000.6496. View

Sarela A, Macadam R, Farmery S, Markham A, Guillou P . Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma. Gut. 2000; 46(5):645-50. PMC: 1727921. DOI: 10.1136/gut.46.5.645. View

Konno R, Yamakawa H, Utsunomiya H, Ito K, Sato S, Yajima A . Expression of survivin and Bcl-2 in the normal human endometrium. Mol Hum Reprod. 2000; 6(6):529-34. DOI: 10.1093/molehr/6.6.529. View

Adida C, Haioun C, Gaulard P, Lepage E, Morel P, Briere J . Prognostic significance of survivin expression in diffuse large B-cell lymphomas. Blood. 2000; 96(5):1921-5. View

OConnor D, Grossman D, Plescia J, Li F, Zhang H, Villa A . Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. Proc Natl Acad Sci U S A. 2000; 97(24):13103-7. PMC: 27185. DOI: 10.1073/pnas.240390697. View

Adida C, Recher C, Raffoux E, Daniel M, Taksin A, Rousselot P . Expression and prognostic significance of survivin in de novo acute myeloid leukaemia. Br J Haematol. 2000; 111(1):196-203. DOI: 10.1046/j.1365-2141.2000.02328.x. View

Islam A, Kageyama H, Hashizume K, Kaneko Y, Nakagawara A . Role of survivin, whose gene is mapped to 17q25, in human neuroblastoma and identification of a novel dominant-negative isoform, survivin-beta/2B. Med Pediatr Oncol. 2000; 35(6):550-3. DOI: 10.1002/1096-911x(20001201)35:6<550::aid-mpo12>3.0.co;2-y. View

10.

Takamizawa S, Scott D, Wen J, Grundy P, BISHOP W, Kimura K . The survivin:fas ratio in pediatric renal tumors. J Pediatr Surg. 2001; 36(1):37-42. DOI: 10.1053/jpsu.2001.20000. View

11.

Shin S, Sung B, Cho Y, Kim H, Ha N, Hwang J . An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochemistry. 2001; 40(4):1117-23. DOI: 10.1021/bi001603q. View

12.

Takano Y, Kato Y, Masuda M, Ohshima Y, Okayasu I . Cyclin D2, but not cyclin D1, overexpression closely correlates with gastric cancer progression and prognosis. J Pathol. 1999; 189(2):194-200. DOI: 10.1002/(SICI)1096-9896(199910)189:2<194::AID-PATH426>3.0.CO;2-P. View

13.

Monzo M, Rosell R, Felip E, Astudillo J, Sanchez J, Maestre J . A novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers. J Clin Oncol. 1999; 17(7):2100-4. DOI: 10.1200/JCO.1999.17.7.2100. View

14.

Li F, Ackermann E, Bennett C, Rothermel A, Plescia J, Tognin S . Pleiotropic cell-division defects and apoptosis induced by interference with survivin function. Nat Cell Biol. 1999; 1(8):461-6. DOI: 10.1038/70242. View

15.

Mahotka C, Wenzel M, Springer E, Gabbert H, Gerharz C . Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties. Cancer Res. 2000; 59(24):6097-102. View

16.

Tanaka K, Iwamoto S, Gon G, Nohara T, Iwamoto M, Tanigawa N . Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res. 2000; 6(1):127-34. View

17.

Okada E, Murai Y, Matsui K, Isizawa S, Cheng C, Masuda M . Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients. Cancer Lett. 2001; 163(1):109-16. DOI: 10.1016/s0304-3835(00)00677-7. View

18.

Gianani R, Jarboe E, Orlicky D, Frost M, Bobak J, Lehner R . Expression of survivin in normal, hyperplastic, and neoplastic colonic mucosa. Hum Pathol. 2001; 32(1):119-25. DOI: 10.1053/hupa.2001.21897. View

19.

Xing N, Qian J, Bostwick D, Bergstralh E, Young C . Neuroendocrine cells in human prostate over-express the anti-apoptosis protein survivin. Prostate. 2001; 48(1):7-15. DOI: 10.1002/pros.1076. View

20.

Fogt F, Poremba C, Shibao K, Itoh H, Kohno K, ZIMMERMAN R . Expression of survivin, YB-1, and KI-67 in sporadic adenomas and dysplasia-associated lesions or masses in ulcerative colitis. Appl Immunohistochem Mol Morphol. 2001; 9(2):143-9. DOI: 10.1097/00129039-200106000-00007. View